Table 2.

Coagulation parameter and platelet count thresholds prior to high-bleeding-risk procedures in patients with cirrhosis

EASL 202253 ISTH 202152 AASLD 202151 AGA 202150 ACG 202049 SIR 201948 
INR Do not correct Do not evaluate routinely Do not correct Do not evaluate routinely Do not correct INR ≥2.5 
Platelet count Do not correct Do not correct Do not correct Do not evaluate routinely ≥50 000/µL ≥30 000/µL 
Fibrinogen Do not correct Do not evaluate routinely Do not correct Do not evaluate routinely No specific recommendation ≥1 g/L 
Viscoelastic assay Do not use routinely Do not use routinely Do not use routinely No recommendation May be useful No specific recommendation 
EASL 202253 ISTH 202152 AASLD 202151 AGA 202150 ACG 202049 SIR 201948 
INR Do not correct Do not evaluate routinely Do not correct Do not evaluate routinely Do not correct INR ≥2.5 
Platelet count Do not correct Do not correct Do not correct Do not evaluate routinely ≥50 000/µL ≥30 000/µL 
Fibrinogen Do not correct Do not evaluate routinely Do not correct Do not evaluate routinely No specific recommendation ≥1 g/L 
Viscoelastic assay Do not use routinely Do not use routinely Do not use routinely No recommendation May be useful No specific recommendation 

AASLD, American Association for the Study of Liver Diseases; ACG, American College of Gastroenterology; AGA, American Gastroenterological Association; EASL, European Association for the Study of the Liver; ISTH, International Society on Thrombosis and Haemostasis; SIR, Society of Interventional Radiology.

or Create an Account

Close Modal
Close Modal